These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16740697)

  • 1. Regression of latent endometrial precancers by progestin infiltrated intrauterine device.
    Ørbo A; Rise CE; Mutter GL
    Cancer Res; 2006 Jun; 66(11):5613-7. PubMed ID: 16740697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.
    Lin MC; Burkholder KA; Viswanathan AN; Neuberg D; Mutter GL
    Cancer; 2009 May; 115(10):2111-8. PubMed ID: 19280590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Vereide AB; Kaino T; Sager G; Ørbo A;
    Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.
    Monte NM; Webster KA; Neuberg D; Dressler GR; Mutter GL
    Cancer Res; 2010 Aug; 70(15):6225-32. PubMed ID: 20631067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.
    Mutter GL; Monte NM; Neuberg D; Ferenczy A; Eng C
    Cancer Res; 2014 May; 74(10):2796-802. PubMed ID: 24662919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular identification of latent precancers in histologically normal endometrium.
    Mutter GL; Ince TA; Baak JP; Kust GA; Zhou XP; Eng C
    Cancer Res; 2001 Jun; 61(11):4311-4. PubMed ID: 11389050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involution of PTEN-null endometrial glands with progestin therapy.
    Zheng W; Baker HE; Mutter GL
    Gynecol Oncol; 2004 Mar; 92(3):1008-13. PubMed ID: 14984979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.
    Mutter GL; Lin MC; Fitzgerald JT; Kum JB; Baak JP; Lees JA; Weng LP; Eng C
    J Natl Cancer Inst; 2000 Jun; 92(11):924-30. PubMed ID: 10841828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.
    Reyes HD; Carlson MJ; Devor EJ; Zhang Y; Thiel KW; Samuelson MI; McDonald M; Yang S; Stephan JM; Savage EC; Dai D; Goodheart MJ; Leslie KK
    Gynecol Oncol; 2016 Jan; 140(1):152-60. PubMed ID: 26524723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.
    Cholakian D; Hacker K; Fader AN; Gehrig PA; Tanner EJ
    Gynecol Oncol; 2016 Feb; 140(2):234-8. PubMed ID: 26706662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis.
    Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():104-110. PubMed ID: 30342311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
    Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
    Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precancerous lesions of the endometrium and medical treatment.
    Taddei GL; Bargelli G; Scarselli B; Moncini D; Scarselli G
    Eur J Contracept Reprod Health Care; 1997 Dec; 2(4):239-41. PubMed ID: 9678079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.
    Wang S; Pudney J; Song J; Mor G; Schwartz PE; Zheng W
    Gynecol Oncol; 2003 Feb; 88(2):108-17. PubMed ID: 12586588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.
    Ricciardi E; Maniglio P; Frega A; Marci R; Caserta D; Moscarini M
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1934-7. PubMed ID: 23242719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.
    Penner KR; Dorigo O; Aoyama C; Ostrzega N; Balzer BL; Rao J; Walsh CS; Cass I; Holschneider CH
    Gynecol Oncol; 2012 Mar; 124(3):542-8. PubMed ID: 22079678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of PAX2 and PTEN Correlates to Therapy Response in Endometrial Hyperplasia.
    Ørbo A; Arnes M; Lyså LM; Straume B
    Anticancer Res; 2015 Dec; 35(12):6401-9. PubMed ID: 26637849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.
    Kim MK; Seong SJ; Song T; Kim ML; Yoon BS; Jun HS; Lee GH; Lee YH
    Gynecol Oncol; 2013 Sep; 130(3):470-3. PubMed ID: 23822890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.